Fandy, Tamer E <br/><br/>
Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2014 
 - 1249-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-1453  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Antioxidants--metabolism<br/>Apoptosis--drug effects<br/>Azacitidine--analogs & derivatives<br/>Caspases--metabolism<br/>Cell Cycle Checkpoints<br/>Cell Line, Tumor<br/>DNA (Cytosine-5-)-Methyltransferase 1<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methylation<br/>Decitabine<br/>Drug Resistance, Neoplasm--genetics<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Gene Knockdown Techniques<br/>Humans<br/>Leukemia--enzymology<br/>Matrix Metalloproteinases--metabolism<br/>Oxidation-Reduction<br/>Reactive Oxygen Species--metabolism<br/>Transcriptional Activation<br/>Tumor Suppressor Protein p53--metabolism